Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The COPCOV trial is approaching its final months of recruitment. As of 14 Sept, COPCOV sites have enrolled 2,848 study participants. New sites in Benin, Côte d’Ivoire, Indonesia, Kenya and Nepal joined those in Mali, Pakistan and Zambia, and now closed sites in Thailand, Niger and the UK. We plan to finish recruitment of new participants by the end of Sept, although that may be extended to the end of Oct with local team approval where drug shelf-life allows and further recruitment is possible.